A detailed history of Bbjs Financial Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bbjs Financial Advisors, LLC holds 133 shares of BMY stock, worth $5,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133
Previous 132 0.76%
Holding current value
$5,327
Previous $6.76 Million 6.98%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$47.98 - $54.4 $47 - $54
1 Added 0.76%
133 $7.24 Million
Q4 2023

Feb 28, 2024

BUY
$48.48 - $57.85 $96 - $115
2 Added 1.54%
132 $6.76 Million
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $57 - $64
1 Added 0.78%
130 $7.57 Million
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $63 - $70
1 Added 0.78%
129 $8.26 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $65 - $74
1 Added 0.79%
128 $8.88 Million
Q4 2022

Feb 24, 2023

BUY
$68.48 - $81.09 $8,696 - $10,298
127 New
127 $9.14 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bbjs Financial Advisors, LLC Portfolio

Follow Bbjs Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbjs Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbjs Financial Advisors, LLC with notifications on news.